Sandy Zweifach

State Street Bank & Trust Co. (SSBT) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1792 and is owned by State Street Corp. (NYSE: STT). SSBT serves as the administrator, fund accountant and transfer agent for the WisdomTree Bitcoin Fund, an exchange-traded fund.

Signature BioScience, Inc. discovers new drugs by applying its parallel target and compound selection process. The private company is based in Hayward, CA and has subsidiaries in the United States. The company was founded by Andrew Peter Sandham and John Hefti.

Neuberger Berman BD LLC is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. It is directly owned by Neuberger Berman Investment Advisers LLC, which is an indirect, wholly-owned subsidiary of Neuberger Berman Group LLC, which is owned by NBSH Acquisition LLC. The firm traces their origin back to the 1939 founding of Neuberger & Berman, its predecessor firm. In 1950, Neuberger Berman became one of the first firms to offer a no-load mutual fund to individual investors. Neuberger Berman BD manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Mayo Clinic provides health care services. Its products and services include healthy living program, sports medicine, Mayo clinic health letter, medical products, population health and wellness programs, medical laboratory services and mayo clinic voice apps. The firm offers medical services in the areas of dermatology, allergy, hypertension, neurology, oncology, psychiatry, radiation oncology, and rheumatology. The company was founded by William J. Mayo and Charles H. Mayo in 1986 and is headquartered in Rochester, MN.

Perella Weinberg Partners LP (PWP) is the registered broker/dealer subsidiary of Perella Weinberg Partners Group LP. Headquartered in New York City, the firm was founded in 2005 by Joe Perella, Peter Weinberg and Tarek Abdel-Meguid. PWP offers full spectrum of brokerage services to retail clients.

Summit Materials LLC manufactures construction materials. It uses its materials internally to produce ready-mixed concrete and asphalt paving mix. The firm operates through the following segments: West, East, and Cement. The company was founded by Thomas W. Hill in 2009 and is headquartered in Denver, CO.

Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT.

Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA.

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

Qrativ, Inc. operates drug purposing platform for reinventing the way treatments for diseases with unmet medical need. It specializes in mayo clinic, nference, drug discovery, drug development, repurposing, rare diseases, complex diseases, artificial intelligence and biotechnology. The company was founded by Murali Aravamudan, Andrew Badley and Venky Soundararajan in 2017 and is headquartered in Cambridge, MA.

Partners Group Inc. (United States) is a Private Equity/Venture Capital firm, a subsidiary of Partners Group (Private Equity) founded in 2000. The firm is headquartered in Houston.

Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA.

Rivonia Road Capital LLC (Rivonia Road Capital) is a private equity firm founded in 2017 by Bradley Smiedt and Daniel J. Zinn. Rivonia. The firm is headquartered in Santa Monica, California.

Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill.

Micronoma, Inc. is a cancer-detection company that uses signals from circulating microbial nucleic acids in blood to diagnose cancer at an early stage with microbiome-driven liquid biopsy technology. Micronoma is headquartered in San Diego, CA. The company aims to revolutionize and advance the practice of early cancer diagnostics and personalized treatment through sensitive microbiome techniques, ensuring that patients' needs are identified and addressed by their clinicians at the earliest stage for a better chance to live longer, healthier lives. The company was founded in 2019 by Sandrine Miller-Montgomery, Greg Poore, Rob Knight, and Magda Marquet. Sandrine Miller-Montgomery has been the CEO since 2019.

Part of Precision Medicine Group LLC, Project Farma, Inc. is a patient-focused consulting firm providing biomanufacturing strategy and execution for the life science industry. The company is based in Bethesda, MD. The company offers technical operations strategies such as pipeline evaluation and mobilization, make vs buy, and gmp infrastructure and startup. Additionally, they manage capital projects, cdmo selection and management, tech transfers and facility builds, and provide engineering services in automation, validation, quality, reliability, and maintenance. Project Farma's clients include startups, established life science corporations, advanced therapy organizations, universities, hospitals, government agencies, financial institutions, not-for-profits, and cros/cmos. The company was founded by Anshul Mangal. Project Farma was acquired by Precision Medicine Group LLC on January 14, 2021.

Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg.

WIT LLC is a family offices headquartered in Washington, DC. The firm is owned by Walton Enterprises LLC and they manage the assets of the Walton family and their related entities.

Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY.

Hunting Hill Global Capital LLC (Hunting Hill) is an independent hedge fund management firm headquartered in New York City. The firm was founded by Adam Guren and Chidozie Ugwumba in 2010. Hunting Hill serves as investment manager to pooled investment vehicles and separately managed accounts. Investors in the Hunting Hill Funds are financially sophisticated individuals and institutional investors.